HedgeChatter

  • Home /
  • Tag Archives

OCRX

4:36 pm Ocera Therapeutics –CORRECTION– PCRX announced a common stock offering; earlier we reported it was OCRX; we have removed the initial post

moreView todays social media effects on OCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Ocera is hiring next, click here to view […]

April 8, 2014 Bystocknews , Comments Off on 4:36 pm Ocera Therapeutics –CORRECTION– PCRX announced a common stock offering; earlier we reported it was OCRX; we have removed the initial post read more

Tranzyme Pharma to Report Fourth Quarter and Full-Year 2012 Financial Results

[at noodls] – RESEARCH TRIANGLE PARK, N.C., March 13, 2013 (GLOBE NEWSWIRE) — Tranzyme Pharma (Nasdaq:TZYM), today announced that the Company will report fourth quarter and full-year 2012 financial results after the … moreView todays social media effects on OCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Ocera is hiring next, click here to view […]

March 13, 2013 Bystocknews , Comments Off on Tranzyme Pharma to Report Fourth Quarter and Full-Year 2012 Financial Results read more

Tranzyme Pharma Announces Exploration of Strategic Alternatives

[at noodls] – RESEARCH TRIANGLE PARK, N.C., Feb. 8, 2013 (GLOBE NEWSWIRE) — Tranzyme, Inc. (Nasdaq:TZYM) announced today that its Board of Directors has made a determination to explore and evaluate strategic alternatives, … moreView todays social media effects on OCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Ocera is hiring next, click here to view […]

February 8, 2013 Bystocknews , Comments Off on Tranzyme Pharma Announces Exploration of Strategic Alternatives read more

Tranzyme Pharma Promotes David Moore to Chief Business Officer

[at noodls] – RESEARCH TRIANGLE PARK, N.C., Jan. 15, 2013 (GLOBE NEWSWIRE) — Tranzyme Pharma (Nasdaq:TZYM) today announced that David S. Moore has been named as Chief Business Officer….This is an abstract of the … moreView todays social media effects on OCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Ocera is hiring next, click here to […]

January 15, 2013 Bystocknews , Comments Off on Tranzyme Pharma Promotes David Moore to Chief Business Officer read more

Tranzyme Pharma Announces Successful Completion of Drug Discovery Collaboration With Bristol-Myers Squibb

[at noodls] – Compounds Transferred to Bristol-Myers Squibb for Further Development RESEARCH TRIANGLE PARK, N.C., Jan. 4, 2013 (GLOBE NEWSWIRE) — Tranzyme Pharma (Nasdaq:TZYM), a biopharmaceutical company focused on … moreView todays social media effects on OCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Ocera is hiring next, click here to view […]

January 4, 2013 Bystocknews , Comments Off on Tranzyme Pharma Announces Successful Completion of Drug Discovery Collaboration With Bristol-Myers Squibb read more

Tranzyme Pharma’s DIGEST Trial Stopped for Futility After Interim Analysis of the Phase 2b Results

[at noodls] – RESEARCH TRIANGLE PARK, N.C., Dec. 17, 2012 (GLOBE NEWSWIRE) — Tranzyme Pharma (Nasdaq:TZYM) today announced it is discontinuing and immediately ending patient enrollment in DIGEST, a Phase 2b trial in … moreView todays social media effects on OCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Ocera is hiring next, click here to view […]

December 17, 2012 Bystocknews , Comments Off on Tranzyme Pharma’s DIGEST Trial Stopped for Futility After Interim Analysis of the Phase 2b Results read more

Tranzyme Pharma Announces Resignation of Chief Financial Officer

[at noodls] – RESEARCH TRIANGLE PARK, N.C., Dec. 5, 2012 (GLOBE NEWSWIRE) — Tranzyme Pharma (Nasdaq:TZYM), today announced that Richard I. Eisenstadt, Vice President, Finance and Chief Financial Officer, has resigned … moreView todays social media effects on OCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Ocera is hiring next, click here to view […]

December 5, 2012 Bystocknews , Comments Off on Tranzyme Pharma Announces Resignation of Chief Financial Officer read more

Tranzyme Pharma to Speak at Piper Jaffray Healthcare Conference

[at noodls] – RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2012 (GLOBE NEWSWIRE) — Tranzyme Pharma (Nasdaq:TZYM), today announced that Vipin K. Garg, Ph.D., President and CEO, will speak at the 24th Annual Piper Jaffray … moreView todays social media effects on OCRXView the latest stocks trending across Twitter. Click to view dashboard […]

November 20, 2012 Bystocknews , Comments Off on Tranzyme Pharma to Speak at Piper Jaffray Healthcare Conference read more